Company: ISRG
Filing Date: 2025-03-14
Form Type: DEF 14A
Source: 0001035267-25-000098
Chunk: 42

Company: INTUITIVE SURGICAL INC
Filing Date: 2025-03-14
Form: DEF 14A
Chunk 42
---
 service. The PSUs generally vest on the three-year anniversary of the grant date, subject to continued service through such date. The PSUs have an overall payout range of 75% of target to 125% of target, as determined by the Compensation Committee.

For the 2024 PSU program (granted in 2024), one-third of the PSUs are eligible to be earned based on the Company’s total shareholder return (“TSR”) relative to the Standard & Poor’s Healthcare Equipment Select Index (the “Peer Group Index”) over the performance period, while the remaining two-thirds of the PSUs are eligible to be earned based on the achievement of specified da Vinci and Ion procedure growth targets based on multi-year periods within the overall performance period.

For each metric, no shares will be earned if the actual performance is below the threshold attainment level. We believe that the design of our PSU programs provides a strong long-term focus on both operational and stock-based performance of the Company.

The below table outlines the metrics by which the 2024 PSUs are eligible to be earned as well as the earned/vested PSU payout achievement factor for the achievement of threshold, target, or maximum performance.

|                                         |     |           |     | % Earned/Vested |     |        |     |         |
| 2024 PSU Program Metrics                |     | Weighting |     | Threshold       |     | Target |     | Maximum |
| 2023 vs. 2025 Procedure Count Growth(1) |     | 33.3%     |     | 75%             |     | 100%   |     | 125%    |
| 2023 vs. 2026 Procedure Count Growth(2) |     | 33.3%     |     | 75%             |     | 100%   |     | 125%    |
| Relative TSR(3)                         |     | 33.3%     |     | 75%             |     | 100%   |     | 125%    |

(1) Calculated as the combined da Vinci and Ion procedure count for the year ended December 31, 2025, less the combined da Vinci and Ion procedure count for the year ended December 31, 2023.

(2) Calculated as the combined da Vinci and Ion procedure count for the year ended December 31, 2026, less the combined da Vinci and Ion procedure count for the year ended December 31, 202